Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-732-0 | CAS number: 1655-29-4
Endpoint summary
Administrative data
Description of key information
No skin or eye irritation was seen in early in vivo studies with limited documentation on the test compound.
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
A study was performed for the assessment of the skin irritancy of Armstrongsaure-di-Natriumsalz with reconstructed human epidermis (RhE; OECD TG 439). No skin irritation potential was observed.
In vitro studies for assessing ocular irritation properties of the test item Armstrongsaure-di- Natriumsalz was performed using the reconstructed human cornea-like epithelium (RhCE) cell model EpiOcular™ (OECD TG 492) and the Bovine Corneal Opacity and Permeability test(BCOP) using fresh bovine cornea (OECD TG 437). In both tests Armstrongsaure-di-Natriumsalz was characterized by having no potential to damage the eye.
The in vitro data confirm the early in vivo studies. No skin or eye irritation was observed for Armstrongsaure-di- Natriumsalz.
Justification for classification or non-classification
No classification is warranted because no skin or eye irritation was seen in early in vivo studies with limted docuentation on the test compound. Recent in vitro studies confirm that Armstrongsäure-di-Natrium salt is not irritating to the skin or eye.EMCSP
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
